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Minimally invasive diagnosis of renal artery stenosis by spiral com-
puted tomography angiography. We prospectively compared in a blinded
fashion spiral computed tomography angiography (CTA) with arteriogra-
phy in 62 consecutive patients with suspected renal artery stenosis (RAS).
For CTA 150 ml of contrast material were injected intravenously. Arte-
riography was performed by DSA technique with selective catheterization
of renal arteries. Of the 157 visualized renal arteries 155 could be
evaluated with DSA and a total of 157 with CTA. Sensitivity of CTA for
RAS  50% was 98% and the specificity was 94%. Comparison of the
grade of stenosis as evaluated by DSA versus CTA showed: identical
gradation in 59 arteries (DSA  50%/CTA 50%), underestimation by
CTA in one artery (DSA 50 to 75%ICTA < 50%), and overestimation by
CTA in six arteries (DSA < 50%/CTA 50 to 75%). Factors that may
contribute to these differences include impaired renal function and
possibly "underestimation" of ostial RAS by arteriography. One artery not
evaluable by arteriography showed a 70% stenosis by CTA. CTA showed
no major side effects. We conclude that CTA has the same accuracy for
the diagnosis of RAS  50% as arteriography. However, CTA is only
minimally invasive, safe, and causes less discomfort to patients.
In 0.5 to 5% of patients with hypertension renal artery stenosis
(RAS) is the underlying cause [1—3]. Due to its progressive nature
and the high incidence of bilateral involvement (P— 30%) RAS
may lead to severe renal impairment and end-stage renal disease
(ESRD) [4—lU]. Angioplasty or vascular surgery may cure RAS-
induced hypertension and prevent RAS-induced ESRD. Hence,
the accurate diagnosis of RAS is of great importance [11].
Arteriography has been the gold standard for diagnosis of RAS. It
is invasive, potentially dangerous, and associated with patient
discomfort. To avoid these adverse effects, diagnostic vascular
imaging methods have been sought that are less invasive, less
expensive, and less dangerous, including intravenous digital sub-
traction angiography (i.v.DSA) and magnetic resonance angiog-
raphy. Both methods have significant limitations. Intravenous
DSA is prone to many artifacts and its overall sensitivity and
specificity are not satisfactory [12, 13]. MR angiography renders
reliable results only in the first three centimeters of the renal
arteries [14, 15]. Computed tomography angiography (CTA) is a
new, minimally invasive technique for vascular imaging that is
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based on spiral computed tomography. It has the potential to
combine the diagnostic accuracy of arteriography with the low risk
of intravenous DSA [16]. In a previous study we evaluated the
technical details of CTA and established the optimal method of
image analysis with respect to renal artery stenosis [17]. In the
present study we prospectively compared the standardized and
optimized CTA with arteriography in 62 consecutive patients with
suspected renal artery stenosis.
Methods
Study population
Between December 1992 and March 1994 62 consecutive
patients with suspected renal artery stenosis (RAS) were studied.
The demographic data are given in Table 1. All patients had a
history of hypertension with diastolic blood pressure exceeding 95
mm Hg. Serum creatinine exceeded 150 .rmol/liter in 15 patients
(24%). Malignant hypertension, hypertension with unexplained
impairment of renal function, presence of flank bruits, hyperten-
sion accompanied by occlusive disease in coronary and peripheral
circulation, and sudden worsening of hypertension were the
clinical criteria leading to the suspicion of RAS [18]. It was
supplemented by positive results in screening tests, including
captopril scintigraphy and Doppler ultrasound. The patients were
examined by CTA followed by arteriography. The median time
interval between the two procedures was one day (range 1 to 45
days). Blood pressure was measured prior to, between and
following the radiologic examinations. Serum creatinine was
measured prior to and after CTA and arteriography.
Arteriography (DSA)
Arteriography was performed by DSA technique with a trans-
femoral approach. A flush aortography with 30 ml of non-ionic
contrast material (iopromide, 300 mg iodine per ml, Ultravist 300;
Schering AG, Berlin, Germany) using 5-F pigtail catheters was
followed by selective renal angiography. Angioplasty was per-
formed during the same session in patients with renal artery
stenosis  50% where it was not contraindicated.
The DSA studies were independently reviewed by two radiol-
ogists (A.C. and C.S.) using a predefined rating system, and a
consensus was subsequently obtained. The grading of stenosis was
defined as follows: Grade 0, no stenosis; Grade 1, stenosis below
50%; Grade 2, stenosis between 50 and 75%; Grade 3, stenosis
between 75 and 99%; Grade 4, occlusion. The evaluation of the
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Table 1. Description of study population
Patients, N 62
Age, years Median 53, Range 20—79
Female:Male 23:39
Body mass index 26 3.2
Systolic BP, mm Hg 163 22
Diastolic BP, mm Hg 95 12
initial serum creatinine, pmol/liter Median 102, Range 52—1145
Serum creatinine > 150 pmol/liter 15 (24%)
Smoker 33 (53%)
Coronary heart disease 22 (35%)
Peripheral vascular disease 13 (21%)
Diabetes mellitus 11(18%)
DSA studies was performed in a blinded fashion without previous
knowledge of the results of spiral CTA.
Spiral CT angiography
The CTA examinations were carried out as described previ-
ously [17] with a Somatom Plus S scanner (Siemens AG, Erlan-
gen, Germany). The examinations always started with a localizer
scan beginning at the level of the 12th thoracic vertebra and
covering the kidneys below that level. Subsequently, 10 to 15 ml of
non-ionic contrast material (iopromide, 300 mg iodine per ml,
Ultravist 300; Schering AG, Berlin, Germany) was manually
injected into an arm vein as a bolus, and a short dynamic sequence
of scans were obtained approximately at the level of the renal
arteries. The transit time required for the contrast medium to
traverse the distance from the point of injection to the abdominal
aorta was estimated as the time interval between start of injection
and maximum contrast enhancement of the aorta. For the subse-
quent spiral scan, this transit time was increased by 2 to 5 seconds
to take into account that maximum contrast would be reached
later if a much larger contrast material volume (such as 100 to 150
ml for CTA) was injected. Spiral scanning was started at the level
of the origin of the superior mesenteric artery (point of refer-
ence). Between 100 and 150 ml of non-ionic contrast material
(iopromide, 300 mg iodine per ml, Ultravist 300; Schering AG)
was injected with an automatic injector (CT injector; Ulrich, Ulm,
Germany) at a flow rate of 3.5 to 4.0 mi/sec. For patients with a
body wt of less than 60 kg the contrast medium volume was
determined by weight (2.5 mI/kg), but in no patient was less than
100 ml required. The flow rate was increased to 5 mI/sec in young
patients (< 35 years) with a measured transit time of less than 15
seconds to compensate for an increased dilution effect caused by
high cardiac output. If less than 125 ml of contrast material was
injected, the flow rate was reduced to 3 mI/sec to maintain
sufficient vascular contrast during the late phase of scanning. The
average time required for examination of a patient was 20
minutes. The reconstruction of axial images at Ito 2 mm intervals
from the spiral scan raw data required another 5 to 7 minutes.
Image analysis
For each case, three different methods of image analysis were
performed with commercially available standard scanner soft-
ware, including interactive viewing of multiplanar reconstruction
images in cine mode, maximum intensity projections (MIP), and
three-dimensional reconstructions, as described recently (Figs. 1
and 2) [17]. The CTA image analysis was independently per-
formed by two radiologists (M.G. and M.P.) using the predefined
rating system described above, and a consensus was subsequently
obtained. The evaluation of the CT scans was performed in a
blinded fashion without previous knowledge of the results of
arteriography. The duration of viewing and analysis of CTA
images required an average of 17 minutes. Three-dimensional
editing and calculation of MIPs accounted for another 15 minutes.
Results
CTA was perfomed in the 62 patients without major side
effects. The injected contrast volume was 141 17 ml. Serum
creatinine remained unchanged 24 hours after examination. The
median value before examination was 102 .tmo1/liter (range 52 to
1145 jimol/liter) and 108 j.tmol/liter (range 59 to 1098 jimol/liter)
after examination. The mean difference was 8 jmol/liter (95%
confidence interval —6.7 to 22.8 moi/liter). The difference was
not significant (P = 0.281). The contrast volume injected during
diagnostic DSA was 110 50 ml (N = 24; the contrast volumes
given to the 38 patients undergoing angioplasty are not included
in this mean volume). This is a significantly lower volume in
comparison to CTA (mean difference, —30.3 ml, 95% confidence
interval —44.8 ml to —15.7 ml, P < 0.0005). DSA was complicated
by the following events: major puncture site hematoma that
required surgery in one patient following angioplasty; minor
puncture site hematoma not requiring surgery or transfusion, in
three patients (1 with angioplasty); and bradycardia in one. An
increase in serum creatinine with complete return to initial values
within two weeks was observed in two patients (97 to maximum
133 jimol/liter, interval between CTA and DSA 45 days; 92 to
maximum 179 amol/liter, interval between CTA and DSA 1 day).
An increase in creatinine level that did not return to initial values
within two weeks was present in two patients (97 to 115 .tm 01/liter,
interval between CTA and DSA 1 day; 85 to 124 mol/liter,
interval between CTA and DSA 3 days). All changes in creatinine
levels were associated with renal artery angioplasty.
Thirty-eight patients underwent angioplasty und two patients
received aorto-renal bypass surgery.
Stenosis grading
One hundred and twenty kidneys were identified in the 62
patients. Three patients had renal transplants, and one patient
had unilateral renal agenesis. A total of 157 renal arteries were
visualized by DSA: 88 kidneys had one renal artery, 27 kidneys
had two, and five kidneys had three renal arteries, respectively.
The number of renal arteries was correctly identified by CTA in
all kidneys. Table 2 summarizes the DSA and CTA results. Two
renal arteries could not be adequately evaluated by DSA due to
the fact that the arteries arose immediately next to each other
from the aorta. By CTA, adequate evaluation of all renal arteries
was possible. Stenoses of grade I to 4 were detected by DSA in 50
patients involving 87 arteries. CTA showed stenoses of grade 1 to
4 involving 90 renal arteries in 52 patients. Grading of stenoses by
CTA and by DSA had a correlation coefficient of 0.95 13 (Spear-
man rank correlation; 95% confidence interval 0.933 1 to 0.9647; P
<0.0001) Clinically relevant RAS  50% was underestimated by
CTA in one case. DSA displayed a 50 to 75% RAS, while the
evaluation by CTA showed a stenosis of less than 50%. In six renal
arteries, CTA suggested RAS of 50 to 75% but DSA showed a
stenosis of less than 50%. A grade 3 stenosis visible by CTA was
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Fig. 1. Grade 3 stenosis of the left renal artery and grade 1 stenosis of the right renal artery. CTA of the renal arteries was performed with 2 mm section
thickness and continuous injection of 150 ml of contrast material. The images a-c are reconstructed from a 3-D data set comprised of a stack of axial
CT-sections. (A, B) Maximum intensity projections (MIP) of the renal arteries in two planes: the structures with maximum density (CT numbers) are
projected into the view plane. In order to obtain angiography like images the bones have been digitally removed from the data set. (C) Three-
dimensional surface reconstruction of the perfused vessel lumen.
not detected by DSA. If DSA is taken as the 100% reference, the Effects of renal function and body mass index
sensitivity of CTA for detection of RAS  50% was 98%, and the
specificity was 94%. The overall sensitivity of CTA for detection Moderate to severe renal function impairment with serum
of renal artery narrowing of any grade was 95%, and the corre- creatinine > 150 imolI1iter was present in 15 patients with 31
sponding specificity was 93%. renal arteries. RAS  50% was detected in 15 arteries by DSA. In
B.r Lr
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Fig. 2. Grade 3 stenosis of the right renal artely. CTA of the renal arteries was performed with 2 mm section thickness and continuous injection of 145
ml of contrast material. The images a and b are reconstructed from a 3-D data set comprised of a stack of axial CT-sections. (A) Maximum intensity
projections (MIP) of the renal arteries; the structures with maximum density (CT numbers) are projected into the view plane. To obtain angiography
like images the bones have been digitally removed from the data set. Lighter areas in the aorta represent atherosclerotic plaques. (B) Three-dimensional
surface reconstruction of the perfused vessel lumens and the kidney.
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14 of these arteries RAS  50% was also present in the CTA
images. RAS  50% was detected by CTA in three additional
arteries. Sensitivity of CTA for RAS  50% in patients with
serum creatinine > 150 irnol/liter was 93%, and the correspond-
ing specificity was 81%. Thirty-six of the present patients were
overweight as indicated by body mass index (BMI) > 25 kg/rn2.
Sensitivity and specificity of CTA were not different in this group.
Discussion
Recently, spiral CT angiography (CTA) has evolved as a new
minimally invasive tool for imaging of the aorta and its large
branch vessels. To evaluate the accuracy of CTA in the diagnosis
of renal artery stenosis (RAS) we prospectively compared in a
blinded fashion CTA with the "gold standard" arteriography.
Both methods detected 157 renal arteries in 62 patients. However,
two arteries could not be evaluated by DSA, while adequate
assessment of all renal arteries was possible by CTA. The grades
of stenosis assigned by CTA and by DSA differed in 22 of the 155
arteries (Table 2), but never by more than one grade. Clinically
relevant RAS  50% was underestimated by CTA in only one
case, where DSA displayed a 50 to 75% RAS and CTA showed a
stenosis of < 50%. Clinically relevant RAS  50% was overesti-
mated by CTA in six cases, where DSA displayed stenoses < 50%
and CTA showed stenoses of 50 to 75%. In four of these seven
discordant cases renal function was substantially impaired, indi-
cated by a serum creatinine exceeding 200 j.mol/liter. Hence, it is
conceivable that impaired renal function may contribute to the
discrepancy. Elevated body mass index and moderate to severe
cardiac insufficiency, other factors that possibly affect CTA, were
not present in the seven patients. The sensitivity of CTA for
detection of RAS  50% was 98%, and the specificity was 94%.
The overall sensitivity of CTA for detection of renal artery
narrowing of any grade was 95%, and the specificity was 93%. The
calculations of both sensitivity and specificity are based on the
assumption that arteriography gives the correct diagnosis of RAS.
However, this premise may not be valid. The accuracy of arteriog-
raphy for diagnosis of renal artery stenosis may not be 100%. For
instance, five out of 51 patients in an arteriography-necropsy study
had moderate to severe stenosis of the aortic orifice of the renal
arteries as demonstrated by necropsy, but the stenoses were not
suspected in the preceding arteriography [19]. Hence, it is con-
ceivable that the higher stenosis grades diagnosed by CTA in 12
renal arteries (Table 2) may be closer to the true vascular anatomy
than the lower grades evaluated by arteriography. Taken together,
the data suggest a similiar diagnostic accuracy of CTA and arterial
DSA for evaluation of main renal arteries.
In recent retrospective comparisons between CTA and conven-
tional renal arteriography lower values of specificity and sensitiv-
ity have been described for CTA in the diagnosis of RAS [20, 21].
In these studies, image analysis was performed solely by three-
dimensional (3D) surface reconstruction and maximum intensity
projections (MIP). In the present study, however, image analysis
was in addition based on interactive viewing of axial sections and
multiplanar reformatted images. As described recently, the diag-
nosis could be best established on axial sections and multiplanar
reformats, while MIP and 3D only rarely added diagnostic infor-
mation. The multiplanar reformats use the primary cross-sectional
data set while 3D surface reconstructions and MIP images reduce
the three dimensional data set to get two dimensional images of
either "vessel surfaces" or maximum CT numbers [17]. Hence the
difference in image analysis may explain the different outcome in
both studies.
In patients with serum creatinine > 150 mol/liter the sensitiv-
ity of CTA for RAS  50% was 93%, and the specificity was 81%.
These values are lower in comparison to the total population.
Although the numbers are too small for reliable statistical com-
parison we cannot exclude the possibility that moderately to
severely impaired renal function may decrease the diagnostic
accuracy of CTA probably due to reduced renal blood flow.
Another conceivable limitation of CTA may be high body mass
index (BMI). However, sensitivity and specificity of CTA were not
different in patients with a BMI exceeding 25 kg/rn2. Elevated
BMI is unlikely to affect the diagnostic accuracy of CTA. Further
possible limitations of CTA may be poor circulatory status and
stenoses of segmental renal arteries. Both conditions were not
present in this study and cannot be discussed here.
One major complication occurred in association with DSA, a
surgery requiring puncture site hematoma However, the patient
underwent angioplasty, and bleeding may be due to anticoagula-
tion and the larger bore (6F) catheter applied for this procedure.
Arteriography without concomitant angioplasty was accompanied
by a femoral hematoma in one case, and by bradycardia in one
case. This low complication rate is in agreement with larger
studies [22, 23]. CTA was not accompanied by any major side
effects. The effect of both diagnostic procedures, DSA and CTA,
on serum creatinine cannot be derived from the present study due
to the narrow interval of one day between CTA and DSA, and due
to angioplasty performed simultaneously with diagnostic DSA in
38 patients. Indeed, the two transient increases and the two minor
permanent increases in serum creatinine were associated with
renal artery angioplasty. In patients without angioplasty serum
creatinine remained unchanged despite the comparatively high
contrast volume of 141 17 ml in CTA and the narrow interval
between CTA and DSA, indicating a low overall nephrotoxicity. It
is not clear whether the higher dose of contrast may limit the use
of spiral CT angiography in patients with renal insufficiency.
Renal function impairment is a risk factor for contrast nephro-
toxicity, and the risk may rise with increased contrast volume.
However, the risk to develop clinical relevant renal failure follow-
ing contrast injection was low in patients with renal insufficiency in
the absence of diabetes [24, 25]. Furthermore, it is conceivable
that the smaller volume of contrast material injected in aorta and
renal arteries during DSA has the same or even a higher
Table 2. Comparison of stenosis grading by intra-arterial selective
angiography in DSA technique (DSA) and by spiral CT angiography(CTA) of 157 renal arteries in 62 patients
DSA CTA stenosis grade
stenosis
grade
Table shows numbers of renal arteries with respective stenosis grade.
Grades of stenosis: Grade 0, no stenosis; Grade 1, <50%; Grade 2,
50—74%; Grade 3, 75-99%; Grade 4, occlusion. Abbreviation is: NE, not
evaluatable.
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nephrotoxic potential due to the higher local concentration than
the larger intravenous contrast volume in CTA. Many authorities
feel that allergic-type contrast reactions are more common with
intravenous contrast as opposed to the low-volume intraarterial
injections used in DSA. Although we did not observe any allergic
contrast reactions in the present study, this may be another
conceivable disadvantage of CTA.
We conclude that spiral CT angiography is a safe and minimally
invasive method for the diagnosis of renal artery stenosis. The
diagnostic accuracy of CTA is not significantly different from
arteriography in this series. Conceivable advantages of CTA as
compared to arteriography include the visualization of arterial
lumen as well as of the arterial wall, concomitant depiction of
organ parenchyma, and lack of arterial catheterization. Although
not observed in this study, atheroembolic disease is a devastating
complication of arterial angiography, especially in an elderly
population [26, 27]. CTA would minimize the number of patients
exposed to this complication since contrast material is injected
intravenously. By virtue of the certain and comprehensive infor-
mation that it offers, it can be expected to be superior to the
competitive modalities of color Doppler sonography [28], intra-
venous DSA [12], and renal scintigraphy with ACE inhibitors [29].
Application of CTA can lead to a significant reduction in the
number of diagnostic angiographies in patients with clinically
suspected RAS and thus spare a considerable number of patients
the discomfort and the complications of arteriography. As a
consequence, CTA also facilitates a better patient selection for
renal angiography.
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